Have a feature idea you'd love to see implemented?
Let us know!
CRON Cronos Group Inc
Price (delayed)
$2.05
Market cap
$783.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.12
Enterprise value
-$77.35M
Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology
Highlights
Cronos Group's EPS has surged by 57% YoY and by 14% QoQ
The net income has surged by 56% year-on-year and by 17% since the previous quarter
Cronos Group's gross profit has increased by 45% YoY but it has decreased by 2.2% from the previous quarter
The company's gross margin rose by 11% YoY but it fell by 10% QoQ
The company's quick ratio fell by 21% YoY and by 15% QoQ
The company's debt rose by 5% QoQ and by 3.3% YoY
Key stats
What are the main financial stats of CRON
Market
Valuations
Earnings
Shares outstanding
382.29M
Market cap
$783.7M
Enterprise value
-$77.35M
Price to book (P/B)
0.72
Price to sales (P/S)
7.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.7
Revenue
$111.23M
EBIT
-$107.61M
EBITDA
-$99.62M
Free cash flow
$17.85M
Per share
Balance sheet
Liquidity
EPS
-$0.12
Free cash flow per share
$0.05
Book value per share
$2.83
Revenue per share
$0.29
TBVPS
$2.99
Total assets
$1.18B
Total liabilities
$52.82M
Debt
$980,000
Equity
$1.08B
Working capital
$919.61M
Debt to equity
0
Current ratio
24.24
Quick ratio
22.46
Net debt/EBITDA
8.64
Margins
Efficiency
Dividend
EBITDA margin
-89.6%
Gross margin
14.7%
Net margin
-42.6%
Operating margin
-78%
Return on assets
-4.2%
Return on equity
-4.4%
Return on invested capital
-41.4%
Return on capital employed
-9.4%
Return on sales
-96.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CRON stock price
How has the Cronos Group stock price performed over time
Intraday
1.99%
1 week
-0.97%
1 month
-3.76%
1 year
0.99%
YTD
-1.91%
QTD
-6.39%
Financial performance
How have Cronos Group's revenue and profit performed over time
Revenue
$111.23M
Gross profit
$16.3M
Operating income
-$86.8M
Net income
-$47.44M
Gross margin
14.7%
Net margin
-42.6%
The company's net margin has surged by 66% YoY and by 24% QoQ
The net income has surged by 56% year-on-year and by 17% since the previous quarter
Cronos Group's gross profit has increased by 45% YoY but it has decreased by 2.2% from the previous quarter
Cronos Group's revenue has increased by 30% YoY and by 9% QoQ
Growth
What is Cronos Group's growth rate over time
Valuation
What is Cronos Group stock price valuation
P/E
N/A
P/B
0.72
P/S
7.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.7
Cronos Group's EPS has surged by 57% YoY and by 14% QoQ
The price to book (P/B) is 35% lower than the 5-year quarterly average of 1.1 and 10% lower than the last 4 quarters average of 0.8
Cronos Group's equity has decreased by 3.4% YoY but it has increased by 2.1% from the previous quarter
The price to sales (P/S) is 78% lower than the 5-year quarterly average of 31.6 and 22% lower than the last 4 quarters average of 9.0
Cronos Group's revenue has increased by 30% YoY and by 9% QoQ
Efficiency
How efficient is Cronos Group business performance
The company's return on invested capital has shrunk by 87% YoY and by 17% QoQ
CRON's ROE has soared by 54% YoY and by 17% QoQ
The company's return on assets has surged by 54% YoY and by 18% QoQ
Cronos Group's return on sales has increased by 34% YoY and by 16% QoQ
Dividends
What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CRON.
Financial health
How did Cronos Group financials performed over time
The total liabilities has soared by 58% YoY and by 50% QoQ
The company's quick ratio fell by 21% YoY and by 15% QoQ
The company's debt is 100% lower than its equity
The company's debt rose by 5% QoQ and by 3.3% YoY
Cronos Group's equity has decreased by 3.4% YoY but it has increased by 2.1% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.